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Primary Immunodeficiency and
Related Diseases
In Allergology International (AI ) Vol. 61 No. 2, we
have 6 Review Articles, 11 Original Articles, and 1
Letter-to-the-Editor report. AI is publishing theme is-
sues that include reviews in important fields of cur-
rent research activity written by eminent experts.
The theme of this issue is “Primary Immunodefi-
ciency and Related Diseases”.
Cutaneous manifestations are displayed as both
concomitant or more rarely main symptoms in immu-
nological disorders such as immunedeficiency dis-
ease, autoimmune disease, or autoinflammatory dis-
ease. Patients with immunedeficiency often have cu-
taneous abnormalities (eczema, telangiectasia, mol-
luscum contagiosum, warts, etc.) and chronic eczema
is a common problem, including atopic dermatitis-like
skin lesion. On the other hand, autoinflammatory dis-
ease, which is categorized as a group of inflammatory
disorders that are non-infectious, non-allergic, non-
autoimmune and non-immuno-deficient, also displays
distinctive cutaneous manifestations.1
Tadashi Ariga discusses about Wiskott-Aldrich syn-
drome (WAS), including the renewed clinical and ba-
sic researches for WAS. WAS is characterized clini-
cally with the triad; immunodeficiency, bleeding ten-
dency with microthrombocytopenia and severe ec-
zema. Topical tacrolimus would be effective in some
WAS patients with severe eczema. The pathogenesis
of eczema in WAS remains unknown; however, the
similar basis for atopic dermatitis could be consid-
ered, because high level of IgE and inbalanced cy-
tokine production patterns (Th1 < Th2) are generally
observed.2
Minegishi and Saito discusses comprehensively re-
viewed hyper-IgE syndrome (HIES). HIES is a com-
plex primary immunodeficiency, characterized by
atopic dermatitis-like skin lesion associated with ex-
tremely high serum IgE levels and susceptibility to
infections with extracellular bacteria and fungi. Yoshi-
yuki Minegishi is an excellent pioneer for clinical and
basic researches of HIES and identified that most of
the patients with HIES have dominant negative muta-
tions in STAT3.3
Nobuo Kanazawa is also an excellent pioneer for
Nakajo-Nishimura syndrome. Nakajo-Nishimura Syn-
drome is distinct inherited inflammatory and wasting
disease originally reported from Japan. This disease
usually begins in early infancy with a pernio-like
rashes, especially in winter. The patients develop pe-
riodic fever and nodular erythema-like eruptions, and
gradually progress lipomuscular atrophy in the upper
body. Kanazawa identified homozygous mutation of
PSMB8 gene in this disease, which encodes β 5 i
subunit of immunoproteasome.4
Tomoki Kawai et al. discussed about anhidrotic ec-
todermal dysplasia with immunodeficiency (EDA-ID).
Skin manifestations of EDA-ID include decreased
skin pigmentation, periorbital wrinkling and hyper-
pigmentation, sparse to absent hair, and hypoplastic
to absent sweat glands. NF-κB signaling, through nu-
clear factor-κB (NF-κB) essential modulator (NRMO)
or IκBα, is impaired in this disease.5
More than 20 million people suffer from cedar hay
fever in Japan. In original articles, Makihara et al.
have added solid evidence regarding the efficacy and
safety of intranasal steroid spray for treating Cedar 
Cypress pollenosis.6 Topical steroids cause more un-
desired adverse reactions to the skin and the eyes
compared to the lung and the nose. Ebihara et al.
have reported7 that Tacrolimus ophthalmic suspen-
sion was safe and effective for severe allergic con-
junctivitis and did not increase its concentrations in
blood. Genetic variations of IL-33 and its receptor ST2
are almost always significantly associated with
asthma in the recent large scale genome-wide asso-
ciation studies.8 Morita et al. found the expression of
IL-33 and ST2 mRNA upregulated in the skin after
tape stripping in mice and revealed that IL-33 play a
role in antigen-induced airway eosinophilic inflamma-
tion when the lung had been epicutaneously sensi-
tized with antigen.9 This report suggests the impor-
tance of eczema-related IL-33 for preventing asthma
development.
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